Intranasal COVID-19 Vaccine (E)
The intranasal COVID-19 vaccine candidate, being developed by Bharat Biotech has received regulatory approval for Phase II and III trials. The development of this vaccine is supported by the Department of Biotechnology and Biotechnology Industry Research Assistance Council. Bharat Biotech's intranasal vaccine is the first of its kind COVID-19 jab to undergo human clinical trials in India.
